Original Research

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab

Shakarchi FI, Shakarchi AF, Al-Bayati SA

Clinical Ophthalmology 2019, 13:27-31

Published Date: 19 December 2018